Literature DB >> 7081221

ACP1GUA-1--a low-activity variant of human erythrocyte acid phosphatase: association with increased glutathione reductase activity.

H W Mohrenweiser, J E Novotny.   

Abstract

ACP1GUA-1, a variant of human erythrocyte acid phosphatase, exists as a polymorphism (allele frequency of .132) in the Guaymi Indians of Central America. This variant has an electrophoretic mobility similar to the common B- and C-type variants, but individuals of the ACP1GUA-1 phenotype have a level of enzyme activity only 27% of the activity expected for the ACP1C variant. The GUA-1 variant is more thermostable than is the B variant, and the order of responsiveness to the modulation of activity by purine analogs and folate is always (B)-(A)-(GUA-1). Thus, the GUA-1 variant is a low-activity variant with C-like regulatory properties. Erythrocytes from individuals of the ACP1GUA-1 phenotype have increased basal levels of glutathione reductase, and a larger fraction of the glutathione reductase protein is present as the holoenzyme, indicating increased levels of flavin adenine dinucleotide in the erythrocytes of these individuals. This is consistent with the suggestion that ACP1 has a physiological function as a flavin mononucleotide phosphatase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081221      PMCID: PMC1685341     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Automated reaction rate analysis of erythrocyte glucose-6-phosphate dehydrogenase and glutathione reductase activities.

Authors:  M A Brewster; D H Berry; M N Murphey
Journal:  Biochem Med       Date:  1974-07

2.  Assessment of status riboflavin nutriture by assay of erythrocyte glutathione reductase activity.

Authors:  G E Nichoalds
Journal:  Clin Chem       Date:  1974-05       Impact factor: 8.327

3.  Quantitative genetics of human red cell acid phosphatase.

Authors:  L C Eze; M C Tweedie; M F Bullen; P J Wren; D A Evans
Journal:  Ann Hum Genet       Date:  1974-01       Impact factor: 1.670

4.  Erythrocyte acid phosphatase polymorphism and haemolysis.

Authors:  E Bottini; P Lucarelli; V Bastianon; F Gloria
Journal:  J Med Genet       Date:  1972-12       Impact factor: 6.318

5.  Horizontal polyacrylamide electrophoresis for the determination of serum protein (haptoglobin) and red cell enzyme polymorphisms.

Authors:  H H Hoppe; W Hennig; B Brinkmann
Journal:  Humangenetik       Date:  1972

6.  The red cell acid phosphatase polymorphism in Southern Africa: population data and studies on the R, RA and RB phenotypes.

Authors:  T Jenkins; V Corfield
Journal:  Ann Hum Genet       Date:  1972-04       Impact factor: 1.670

7.  A comparison of some properties of human red cell acid phosphatase in different phenotypes.

Authors:  J E Luffman; H Harris
Journal:  Ann Hum Genet       Date:  1967-05       Impact factor: 1.670

8.  Studies on the separate isozymes of red cell acid phosphatase phenotypes A and B. II. Comparison of kinetics and stabilities of the isozymes.

Authors:  R A Fisher; H Harris
Journal:  Ann Hum Genet       Date:  1971-05       Impact factor: 1.670

9.  Glutathione reductase test with whole blood, a convenient procedure for the assessment of the riboflavin status in humans.

Authors:  D Glatzle; J P Vuilleumier; F Weber; K Decker
Journal:  Experientia       Date:  1974-06-15

10.  Favism: association with erythrocyte acid phosphatase phenotype.

Authors:  E Bottini; P Lucarelli; R Agostino; R Palmarino; L Businco; G Antognoni
Journal:  Science       Date:  1971-01-29       Impact factor: 47.728

View more
  15 in total

1.  Role of genetic variability in neonatal jaundice. A prospective study on full-term, blood group-compatible infants.

Authors:  N Lucarini; F Gloria-Bottini; L Tucciarone; E Carapella; G Maggioni; E Bottini
Journal:  Experientia       Date:  1991-12-01

2.  Taurine mitigates nitrite-induced methemoglobin formation and oxidative damage in human erythrocytes.

Authors:  Fariheen Aisha Ansari; Shaikh Nisar Ali; Riaz Mahmood
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-28       Impact factor: 4.223

3.  Erythrocyte acid phosphatase (ACP1) activity. In vitro modulation by adenosine and inosine and effects of adenosine deaminase (ADA) polymorphism.

Authors:  N Lucarini; P Borgiani; P Ballarini; E Bottini
Journal:  Hum Genet       Date:  1989-01       Impact factor: 4.132

4.  Pentachlorophenol-induced cytotoxicity in human erythrocytes: enhanced generation of ROS and RNS, lowered antioxidant power, inhibition of glucose metabolism, and morphological changes.

Authors:  Nikhil Maheshwari; Fahim Halim Khan; Riaz Mahmood
Journal:  Environ Sci Pollut Res Int       Date:  2019-03-20       Impact factor: 4.223

5.  Interaction at clinical level between erythrocyte acid phosphatase and adenosine deaminase genetic polymorphisms.

Authors:  F Gloria-Bottini; P Lucarelli; A Amante; N Lucarini; G Finocchi; E Bottini
Journal:  Hum Genet       Date:  1989-06       Impact factor: 4.132

6.  Human red cell acid phosphatase (ACP1): evidence for differences in the primary structure of the two isozymes encoded by the ACP1*B allele.

Authors:  J Dissing; G F Sensabaugh
Journal:  Biochem Genet       Date:  1987-12       Impact factor: 1.890

7.  Studies of the purine analog associated modulation of human erythrocyte acid phosphatase activity.

Authors:  K H Wurzinger; J E Novotny; H W Mohrenweiser
Journal:  Mol Cell Biochem       Date:  1985-03       Impact factor: 3.396

8.  Protective effect of carnosine and N-acetylcysteine against sodium nitrite-induced oxidative stress and DNA damage in rat intestine.

Authors:  Fariheen Aisha Ansari; Aijaz Ahmed Khan; Riaz Mahmood
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-04       Impact factor: 4.223

9.  A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphism.

Authors:  N Lucarini; G Finocchi; F Gloria-Bottini; M Macioce; P Borgiani; A Amante; E Bottini
Journal:  Experientia       Date:  1990-01-15

10.  ACP1 and human adaptability. 1. Association with common diseases: a case-control study.

Authors:  E Bottini; F Gloria-Bottini; P Borgiani
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.